American Research & Management Company’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3K | Hold |
300
| – | – | ﹤0.01% | 371 |
|
|
2022
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 348 |
|
|
2022
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 341 |
|
|
2021
Q4 | $10K | Hold |
300
| – | – | ﹤0.01% | 307 |
|
|
2021
Q3 | $8K | Hold |
300
| – | – | ﹤0.01% | 313 |
|
|
2021
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 353 |
|
|
2021
Q1 | $3K | Hold |
300
| – | – | ﹤0.01% | 345 |
|
|
2020
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 360 |
|
|
2020
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 332 |
|
|
2020
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 321 |
|
|
2020
Q1 | $3K | Hold |
300
| – | – | ﹤0.01% | 300 |
|
|
2019
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 309 |
|
|
2019
Q3 | $5K | Hold |
300
| – | – | ﹤0.01% | 301 |
|
|
2019
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 320 |
|
|
2019
Q1 | $4K | Hold |
300
| – | – | ﹤0.01% | 355 |
|
|
2018
Q4 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 306 |
|